期刊文献+

原发性输尿管非尿路上皮癌的临床诊治分析 被引量:1

Clinical diagnosis and treatment of primary non-urothelial carcinoma of ureter
下载PDF
导出
摘要 目的探讨原发性输尿管非尿路上皮癌的临床病理特点、治疗和预后。方法回顾性分析2018年1月-2020年10月就诊于河北省人民医院的5例输尿管非尿路上皮癌患者的临床资料及术后随访情况。其中男性2例,女性3例,平均年龄74(64-83)岁,因腰痛就诊3例,血尿就诊3例。合并高血压3例,肾积水3例,泌尿系感染2例,输尿管结石、右肾萎缩、糖尿病和前列腺癌各1例。1例行放疗,3例行根治性肾输尿管切除术+膀胱袖口状切除术+术后化疗,1例于外院行根治性肾输尿管切除术+膀胱袖口状切除术+免疫治疗。结果病理诊断输尿管小细胞癌2例(合并肾盂小细胞癌1例),鳞癌1例,腺癌(合并肾盂腺癌)1例,淋巴上皮样癌1例。中位随访时间8个月。1例因肿瘤进展于术后4个月死亡,4例生存,其中无病生存3例,1例于确诊后3个月出现腹膜后转移,6个月时出现纵隔转移。结论原发性输尿管非尿路上皮癌发病率低,确诊有赖于术后病理检查,免疫组化有利于各亚型鉴别。治疗首选根治性肾输尿管切除术+膀胱袖口状切除术,预后总体较差,易复发及转移,放化疗及免疫治疗或可改善患者的预后。 Objective To explore the clinicopathological features,treatment and prognosis of primary non-urothelial carcinoma of the ureter.Methods Clinical and follow-up data of 5 patients treated at our hospital during Jan.2018 and Oct.2020 were retrospectively analyzed,including 2 males and 3 females.The patients average age was 74(64-83)years.Three cases went to hospital due to low back pain and 3 due to hematuria.Three cases had hypertension,3 had hydronephrosis,2 had urinary tract infection,1 had ureteral calculi,1 had right renal atrophy,1 had diabetes and 1 had prostate cancer.Radiotherapy was performed in 1 case,radical renal ureterectomy+cystectomy+postoperative chemotherapy in 3 cases,and radical renal ureterectomy+cystectomy+immunotherapy in 1 case.Results There were 2 cases of ureteral small cell carcinoma(1 case complicated with renal pelvis small cell carcinoma),1 case with squamous cell carcinoma,1 case with adenocarcinoma(complicated with renal pelvis adenocarcinoma)and 1 case with lymphoepithelial carcinoma.During the median follow-up of 8 months,1 patient died 4 months after surgery due to tumor progression,and 4 patients survived,3 of whom were disease-free.Retroperi-toneal metastasis was observed in 1 case after 3 months,and mediastinal metastasis occurred after 6 months.Conclusion Primary non-urothelial carcinoma of the ureter is rare,which can be diagnosed with postoperative pathology.Immunohistochemistry is helpful to identify the subtypes.The preferred treatment is radical ureterectomy+cuff bladder resection.However,the prognosis is poor,and recurrence and metastasis frequently occur.Radiotherapy,chemotherapy and immunotherapy may improve the prognosis.
作者 刘良 魏东 李守宾 刘俊江 LIU Liang;WEI Dong;LI Shoubin;LIU Junjiang(Department of Urology,Baoding First Central Hosptial,Baoding 071000;Department of Urology,Hebei General Hospital,Shijiazhuang 050051,China)
出处 《现代泌尿外科杂志》 CAS 2022年第2期148-152,共5页 Journal of Modern Urology
关键词 输尿管肿瘤 小细胞癌 鳞状细胞癌 腺癌 诊断 根治性肾输尿管切除术 放疗 ureteral tumor small cell carcinoma squamous cell carcinoma adenocarcinoma diagnosis radical nephreterectomy radiotherapy
  • 相关文献

参考文献6

二级参考文献64

  • 1朱虎定,孙小燕.肺癌患者血清CEA、CYFRA21-1和NSE检测的临床意义[J].基层医学论坛,2007,11(2):139-140. 被引量:3
  • 2Spira A, Ettinger D S. Multidisciplinary management of lung cancer[J].N Engl J Med, 2004, 350(4):379 - 392.
  • 3Niklinskij, Furman M, Landanskij, et al.Prognostic ralue of pre - treatment CEA, scc - Ag and CA19 - 9 levels in sere of patients with non - small cell ltmg caneer[J] .Eur J Cancer prev, 1992, 1(6) :401 - 406.
  • 4Kalpa J, Wojcik E, Reinfuss M, et al . Carcinoembryonic antige, squamous cell carcinoma antigen CYFRA21 - 1 and neuron -specific enolase in squamous cell lung cancer patients [J]. Clinchem, 2002, 48(1): 1 931.
  • 5Murakim, Tohda Y, Lwanga T, et al . Assessment of serum CYFRA21 - 1 in lung cancer[J]. Cancer, 1996,77:1 274.
  • 6Ebert W, Muley T, Raine C, et al. Comparision of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC [ J]. Auticancer Res, 2002, 22 (28) : 1 083 - 1 085.
  • 7Shibayama T, Vecka H, Nishiik G, et al. Complementary roles of progastrin - releasing peptide (PROGRP) and nearcific enolase(NSE) in diagnosis and prognosis of small- cell lung cancer (SCLC)[J]. Lung cancer, 2001, 32(1):61 -63.
  • 8Munoz J J, Ellison LM. Upper tract urothelial neoplasms: in cidence and survival during the last 2 decades[J]. J Urol 2000,164(5) :1523-1525.
  • 9Olgac S, Mazumdar M, Dalbagni G, et al. Urothelial carci noma of the renal pelvis: a clinicopathologic study of 130 ca ses[J]. AmJ Surg Pathol,2004,28(12):1545- 1552.
  • 10Chen XP, Xiong GY, Li XS, et al. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experi ence from a nationwide high volume centre in China[J]. BJU Int, 2013,112(7) :917-924.

共引文献23

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部